| 9527845 |
Derivatives and methods of treating hepatitis B infections |
George D. Hartman |
2016-12-27 |
| 9518057 |
Derivatives and methods of treating hepatitis B infections |
George D. Hartman |
2016-12-13 |
| 9505722 |
Azepane derivatives and methods of treating hepatitis B infections |
George D. Hartman |
2016-11-29 |
| 9428492 |
Secondary alcohol substituted triazoles as PDE10 inhibitors |
Christopher D. Cox, Vadim Dudkin, Carol A. McVean, Thomas S. Reger, Justin T. Steen |
2016-08-30 |
| 9365562 |
1,3 substituted azetidine PDE10 inhibitors |
Christopher D. Cox, Douglas C. Beshore, June J. Kim, Carol A. McVean, Thomas S. Reger +1 more |
2016-06-14 |
| 9359348 |
Cyclopropyl imidazopyridine PDE10 inhibitors |
Douglas C. Beshore, Thomas S. Reger |
2016-06-07 |
| 9353104 |
Substituted pyridizinone derivatives as PDE10 inhibitors |
Casey Cameron McComas, Thomas S. Reger, Changhe Qi |
2016-05-31 |
| 9339510 |
Azepane derivatives and methods of treating hepatitis B infections |
George D. Hartman |
2016-05-17 |
| 9284312 |
N-methyl tetrahydroquinoline M1 receptor positive allosteric modulators |
Christina Ng DiMarco, Thomas J. Greshock |
2016-03-15 |
| 9284302 |
Cyclobutyl benzimidazoles as PDE 10 inhibitors |
Casey Cameron McComas, Thomas S. Reger |
2016-03-15 |
| 9273033 |
Substituted pyridone derivatives as PDE10 inhibitors |
Casey Cameron McComas, Thomas S. Reger |
2016-03-01 |
| 9260418 |
Pyranyl aryl methyl benzoquinolinone M1 receptor positive allosteric modulators |
Ronald K. Chang, Thomas J. Greshock |
2016-02-16 |
